Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end ...
SC lawmakers advanced a bill that would require a disclaimer for COVID-19 vaccinations. Physicians have broadly encouraged ...
Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.
Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...
6don MSNOpinion
Pfizer is said to divest remaining stake in BioNTech
BioNTech (BNTX) stock slips as Pfizer (PFE) plans to sell its remaining stake in the COVID-19 vaccine developer in a ...
Arturo Bris, IMD professor in geopolitics and business, examines Europe’s often-overlooked innovation engine, unpacking why ...
The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...
BioNTech (NasdaqGS:BNTX) shares caught investors’ attention after Pfizer revealed plans to sell its remaining stake in the company through an overnight block trade. This announcement prompted a wave ...
A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration ...
Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results